The American Cancer Society honors four cancer crusaders

During its annual meeting in Los Angeles this past weekend, the American Cancer Society presented its highest honor, the Medal of Honor, to four Americans who have made "outstanding contributions to the fight for a world with less cancer and more birthdays."

This year's four recipients are:

Lance Armstrong

Awarded the Medal of Honor for Cancer Control.

World-class cyclist, testicular cancer survivor and founder of LIVESTRONG, Armstrong has become the global face of the fight against cancer, advocating for raised awareness and hundreds of millions of government dollars to be redirected towards the fight against cancer.

Said Armstrong, “I am extremely humbled to receive the American Cancer Society’s Medal of Honor. During my own battle with cancer, I established LIVESTRONG with a modest goal to help at least one person affected by this disease. While we exceeded that goal long ago, the burden of cancer tragically continues to grow worldwide."

Arnold J. Levine, Ph.D.

Awarded the Society’s Medal of Honor for Basic Research.

Professor of Pediatrics and Biochemistry at The Cancer Institute of New Jersey, Levine's work has focused on understanding the protein p53 as a tumor suppressor, and according to the ACS, Levine's "pivotal demonstration of the true role of p53 revolutionized thinking about the pathogenesis of cancer."

Said Levine, "As a scientist, it is a privilege to be recognized by an organization which is committed to furthering cancer research. It is also an honor to receive this award in the company of some of the cancer community’s most dedicated individuals. While each of us plays a unique role in our respective areas, it is truly as a collective that we will see our greatest accomplishments in the fight against cancer."

Edward E. Harlow, Ph.D.

Awarded the Society’s Medal of Honor for Basic Research.

Chief scientific officer of Constellation Pharmaceuticals, former chair of the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School, Harlow work has focused on the role viruses and bacteria play in driving tumor formation.

Said Dr. Harlow, "The pleasure of being chosen as a Medal of Honor winner, or for any award in science for that manner, comes primarily from the recognition by your colleagues. Having a group of your peers single out your contributions is remarkable, but it also reminds you of all many steps and individual’s work that combine to allow any significant step forward."

Marvin Zelen, Ph.D.

Awarded the Society's Medal of Honor for Clinical Research.

Professor of Statistical Science at the Harvard School of Public Health and at the Dana-Farber Cancer Institute, Zelen is being recognized for having introduced "statistical science as a pre-eminent component of the national program in cancer clinical trials."

Said Zelen, "I don't regard this Medal as a personal award. Rather, I am a symbol representing the many biomedical scientists, clinical investigators, nurses, data specialists and computer scientists who have worked so hard to make clinical trials in cancer credible for the scientific evaluation of cancer therapies. It is their Medal."

By Ross Bonander
lymphoma roundup

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...